Fulcrum Therapeutics, Inc.
FULCPharmaceutical Preparations · SIC 2834 · CIK 0001680581
Revenue FY2025
$0.0M
Net Income
$(75.0M)
EPS (Basic)
—
Net Margin
—
ROE
-21.5%
Total Equity
$349.0M
Shares Out
76M
Fulcrum Therapeutics, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2018–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 2 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Suvretta Capital Management
Suvretta Capital Management
$13.5M
0.3%
(43.9%)
Adage Capital Management
Adage Capital Management
$7.3M
0.0%
+400.0%
Insider Transactions
Reading stored insider transactions…